ECTRIMS-ACTRIMS 2023: Teriflunomide Associated With Increased Reports of Alopecia in Multiple Sclerosis Patients
No other DMTs studied showed a strong safety signal
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.